$0.5201
0.1438.58%
Last update: Nov 9, 3:03 PM
Estrella Immunopharma Inc
ESLANASDAQ
The average analyst price target for Estrella Immunopharma is $8, 1438.2% above the current price. The one analyst covering it rates it Buy. The latest change came on Jan 28, 2026, when D. Boral Capital lowered its price target on Estrella Immunopharma from $16 to $8 and kept a Buy rating.
Price Target Range — 5 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
